Ionis Pharmaceuticals, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was USD 126 million compared to USD 146 million a year ago. Operating loss was USD 73 million compared to USD 52 million a year ago. Net loss was USD 81 million compared to USD 26 million a year ago. Basic loss per share from continuing operations was USD 0.57 compared to USD 0.18 a year ago. For the half year, total revenue was USD 237 million compared to USD 279 million a year ago. Operating loss was USD 165 million compared to USD 113 million a year ago. Net loss was USD 171 million compared to USD 65 million a year ago. Basic loss per share from continuing operations was USD 1.21 compared to USD 0.47 a year ago.